{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Frefractory-cmv-deep-dive-yoEsIQ_T","width":444,"version":"1.0","type":"rich","title":"Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/d216ca65-6e15-4600-89cd-74277843ed58/100265-cmv-wtc-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/8e641268-3401-477d-94dc-6b2d128966bf\" height=\"200\" width=\"100%\" title=\"Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory cytomegalovirus (CMV) infections to minimize antiviral toxicities and maximize efficacy."}